122 related articles for article (PubMed ID: 2716474)
1. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
Malin DH; Lake JR; Hamilton RF; Skolnick MH
Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
Bousselmame R; Eustache M; Michael-Titus A; Costentin J
Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz JC
Neuropharmacology; 1989 Feb; 28(2):117-22. PubMed ID: 2716968
[TBL] [Abstract][Full Text] [Related]
4. Augmented analgesic effects of L-tryptophan combined with low current transcranial electrostimulation.
Malin DH; Lake JR; Hamilton RF; Skolnick MH
Life Sci; 1990; 47(4):263-7. PubMed ID: 2388530
[TBL] [Abstract][Full Text] [Related]
5. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
Lambert DM; Mergen F; Poupaert JH; Dumont P
Eur J Pharmacol; 1993 Oct; 243(2):129-34. PubMed ID: 8276061
[TBL] [Abstract][Full Text] [Related]
6. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
[TBL] [Abstract][Full Text] [Related]
7. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
Adjroud O
J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
[TBL] [Abstract][Full Text] [Related]
9. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan.
Khallouk-Bousselmame R; Costentin J
Eur Neuropsychopharmacol; 1994 Jun; 4(2):137-43. PubMed ID: 7919943
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.
Lambert DM; Mergen F; Berens CF; Poupaert JH; Dumont P
Pharm Res; 1995 Feb; 12(2):187-91. PubMed ID: 7784331
[TBL] [Abstract][Full Text] [Related]
11. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
Rivière PJ; Buéno L
Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
[TBL] [Abstract][Full Text] [Related]
12. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of mu-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor.
Bousselmame R; Michael-Titus A; Costentin J
Eur J Pharmacol; 1991 Oct; 203(2):295-7. PubMed ID: 1666049
[TBL] [Abstract][Full Text] [Related]
14. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
[TBL] [Abstract][Full Text] [Related]
15. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
[TBL] [Abstract][Full Text] [Related]
17. Analgesia produced by immobilization stress and an enkephalinase inhibitor in amphibians.
Stevens CW; Sangha S; Ogg BG
Pharmacol Biochem Behav; 1995 Aug; 51(4):675-80. PubMed ID: 7675842
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
Livingston SJ; Sewell RD; Rooney KF; Smith HJ
Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
[TBL] [Abstract][Full Text] [Related]
20. [Enkephelinase inhibitors acetorphan and SCH34826 potentiate the analgesic effect of low frequency electroacupuncture in rats].
Zhou Y; Luo F; Han J
Zhen Ci Yan Jiu; 1990; 15(4):310-4. PubMed ID: 2125896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
